Viemed Healthcare, Inc. (VMD) Tops Q4 EPS by 1c, provides guidance

Viemed Healthcare, Inc. (NASDAQ: VMD) reported Q4 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $60.7 million versus the consensus estimate of $58.5 million.

GUIDANCE:

Viemed Healthcare, Inc. sees FY2025 revenue of $254-265 million, versus the consensus of $253.4 million.

Adjusted EBITDA for the year ending December 31, 2025 is expected to be in the range of $54 million to $58 million. See “Forward-Looking Statements” below for further information on this non-GAAP financial guidance.

For earnings history and earnings-related data on Viemed Healthcare, Inc. (VMD) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• DA Davidson Reiterates Buy Rating on Dynatrace Inc. (DT) on Agreement to Acquire Arize
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c